Format

Send to

Choose Destination
Int J Appl Basic Med Res. 2013 Jul;3(2):75-6. doi: 10.4103/2229-516X.117047.

Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance?

Author information

1
Cardiometabolic Research Institute, Houston, Texas, USA.

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center